Quick Answer ABEONA THERAPEUTICS INC. reported Total Revenue of $5.82 million for fiscal year 2025. ABEONA THERAPEUTICS INC. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $5.82M — $3.50M+147.5% $1.41M-52.9% $3.00M-70.0% $10.00M Revenue (ASC 606) $5.82M — $3.50M+147.5% $1.41M-52.9% $3.00M-70.0% $10.00M Net Income $71.18M+211.7% -$63.73M-17.6% -$54.19M-36.5% -$39.70M+53.3% -$84.94M-0.8% -$84.23M-10.4% … Read more
Quick Answer AmBase Corp reported Shares Outstanding of 84.94 million shares for fiscal year 2025. AmBase Corp Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 84.94M +0.0% 2024 84.94M +108.5% 2023 40.74M +0.0% 2022 40.74M +0.0% 2021 40.74M +0.0% 2020 40.74M +0.0% 2019 40.74M +0.0% 2018 40.74M +0.0% 2017 40.74M +0.0% … Read more
Quick Answer AmBase Corp reported Operating Income of -$4.32 million for fiscal year 2025. AmBase Corp Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$4.32M +33.7% 2024 -$6.52M -29.5% 2023 -$5.03M -46.9% 2022 -$3.42M +34.3% 2021 -$5.21M +7.7% 2020 -$5.64M -13.0% 2019 -$4.99M -15.4% 2018 -$4.32M -0.4% 2017 -$4.31M -47.8% 2016 … Read more
Quick Answer AmBase Corp reported Stockholders Equity of -$8.69 million for fiscal year 2025. AmBase Corp Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 -$8.69M -110.5% 2024 -$4.12M +35.0% 2023 -$6.34M -490.8% 2022 -$1.07M -144.8% 2021 $2.40M -68.5% 2020 $7.61M -42.4% 2019 $13.21M -27.2% 2018 $18.14M +1.9% 2017 $17.80M -73.0% 2016 … Read more
Quick Answer AmBase Corp reported Cash and Equivalents of $87.0 thousand for fiscal year 2025. AmBase Corp Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $87.0K -72.3% 2024 $314.0K +302.6% 2023 $78.0K -77.7% 2022 $349.0K -88.4% 2021 $3.00M -62.1% 2020 $7.92M +178.0% 2019 $2.85M +1103.0% 2018 $237.0K +238.6% 2017 … Read more
Quick Answer AmBase Corp reported Long-Term Debt of $3.20 million for fiscal year 2023. AmBase Corp Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2023 $3.20M — 2022 $0.00 — Quarterly Long-Term Debt Quarter Ending Long-Term Debt YoY QoQ March 31, 2024 $3.55M +1082.7% +10.9% December 31, 2023 $3.20M — +73.1% September … Read more
Quick Answer AmBase Corp reported Total Assets of $87.0 thousand for fiscal year 2025. AmBase Corp Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $87.0K -72.3% 2024 $314.0K +302.6% 2023 $78.0K -81.0% 2022 $410.0K -86.7% 2021 $3.08M -61.4% 2020 $7.99M -41.4% 2019 $13.62M -37.4% 2018 $21.75M -0.6% 2017 $21.88M -67.0% 2016 … Read more
Quick Answer AmBase Corp reported Net Income of -$4.56 million for fiscal year 2025. AmBase Corp Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$4.56M +31.1% 2024 -$6.62M -25.6% 2023 -$5.27M -51.8% 2022 -$3.47M +33.3% 2021 -$5.21M +7.1% 2020 -$5.60M -13.8% 2019 -$4.93M -1570.4% 2018 $335.0K +100.7% 2017 -$48.06M -1392.9% 2016 … Read more
Quick Answer AmBase Corp reported Diluted EPS of $0.08 per share (loss) for fiscal year 2016. AmBase Corp Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2016 -$0.08 +27.3% 2015 -$0.11 -131.4% 2014 $0.35 +350.0% 2013 -$0.14 -104.2% 2012 $3.37 +8525.0% 2011 -$0.04 +0.0% 2010 -$0.04 — Quarterly Diluted EPS Quarter Ending … Read more
Quick Answer AmBase Corp reported Net Income of -$4.56 million for fiscal year 2025. AmBase Corp — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Net Income -$4.56M+31.1% -$6.62M-25.6% -$5.27M-51.8% -$3.47M+33.3% -$5.21M+7.1% -$5.60M-13.8% Diluted EPS — — — — — — Total Assets $87.0K-72.3% $314.0K+302.6% $78.0K-81.0% $410.0K-86.7% $3.08M-61.4% $7.99M-41.4% Cash and Equivalents … Read more